Su manejo en enfermos críticos | 19 NOV 12

Síndrome de secreción inadecuada de hormona antidiurética y síndrome de depleción salina cerebral

Se destacan las características particulares del síndrome de secreción inapropiada de hormona antidiurética y de depleción salina cerebral y se presenta una guía para su tratamiento.
Autor/a: Dres. Amanda Zomp, Earnest Alexander AACN Critical Care Volume 23, Number 3, pp.233–239. 2012
INDICE:  1. Artículo | 2. Referencias
Referencias

1. De Vita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol. 1990;34:163–166.
2. Bennani SL, Abougal R, Zeggwagh AA, et al. Incidence, causes and prognostic factors of hyponatremia in intensive care [abstract only]. Rev Med Interne. 2003;24:224–229.
3. Sherlock M, O’Sullivan E, Agha A, et al. Incidence and pathophysiology of severe hyponatremia in neurosurgical patients. Postgrad Med J. 2009;85:171–175.
4. Oster JR, Singer I. Hyponatremia, hyposmolality, and hypotonicity: tables and fables. Arch Intern Med. 1999;159:335.
5. Weisberg LS. Pseudohyponatremia: a reappraisal [review]. Am J Med. 1989;86:315–318.
6. Aabakken L, Johansen KS, Rydningen EB, et al. Osmolal and anion gaps in patients admitted to an emergency medical department. Hum Exp Toxicol. 1994;13:131–134.
7. Greenberg MS. Handbook of Neurosurgery. 6th ed. New York, NY: Thieme Medical Publishers; 2006:12–15.
8. Ferri FF. Practical Guide to the Care of the Medical Patient. 8th ed. Philadelphia, PA: Mosby Inc, an affiliate of Elsevier Inc; 2011:529–530.
9. Bourque CW, Oliet SH, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol. 1994;15:231–274.
10. Lehrich RW, Greenberg A. Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients [published online ahead of print May 13, 2011]. J Intensive Care Med. doi:10.1177/0885066610397016
11. Arieff AI, LLach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine. 1976;55:121–129.
12. Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–1542.
13. Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120:S1–S21.
14. Troyer AD, Demanet JC. Correction of antidiuresis by demeclocycline. N Engl J Med. 1975;293:915–918.
15. Smith D, Moore K, Tormey W, et al. Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am J Physiol Endocrinol Metab. 2004;287:E1019–E1023.
16. Betjes MG. Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med. 2002;13:9–14.
17. Hantman D, Rossier B, Zohlman R, Schrier R. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med. 1973;78:870–875.
18. Forrest JN, Cox M, Hong C, et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med. 1978;298:173–177.
19. Decaux G, Brimioulle S, Genette F, et al. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med. 1980;69:99–106.
20. Decaux G, Genette F. Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br Med J. 1981;283:1081–1083.
21. Hasan D, Lindsay KW, Wijdicks EFM, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 1989;20:1156–1161.
22. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112.
23. Zeltser D, Rosansky S, van Rensburg H, et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J N ephrol. 2007;27:447–457.
24. Potts MB, DeGiacomo AF, Deragopian L, Blevins LS. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion. Neurosurgery. 2011;69:268–273.
25. Wright WL, Abury WH, Gilmore JL, Samuels OB. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11:6–13.
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024